Sutro Biopharma, Inc. (STRO)
15.52
+0.92
(+6.30%)
USD |
NASDAQ |
Feb 06, 16:00
15.55
+0.03
(+0.19%)
After-Hours: 20:00
Sutro Biopharma Profit Margin (Quarterly) : -586.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GT Biopharma, Inc. | -- |
| Rhythm Pharmaceuticals, Inc. | -103.1% |
| Crinetics Pharmaceuticals, Inc. | -90.97K% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.20K% |
| Return on Assets | -66.39% |
| Return on Invested Capital | -101.3% |
| Gross Profit Margin (Quarterly) | 80.40% |
| Operating Margin (Quarterly) | -401.3% |
| Return on Net Operating Assets | -530.7% |